Literature DB >> 21173069

Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture.

Lisa Langsetmo1, Tuan V Nguyen, Nguyen D Nguyen, Christopher S Kovacs, Jerilynn C Prior, Jacqueline R Center, Suzanne Morin, Robert G Josse, Jonathan D Adachi, David A Hanley, John A Eisman.   

Abstract

BACKGROUND: A set of nomograms based on the Dubbo Osteoporosis Epidemiology Study predicts the five- and ten-year absolute risk of fracture using age, bone mineral density and history of falls and low-trauma fracture. We assessed the discrimination and calibration of these nomograms among participants in the Canadian Multicentre Osteoporosis Study.
METHODS: We included participants aged 55-95 years for whom bone mineral density measurement data and at least one year of follow-up data were available. Self-reported incident fractures were identified by yearly postal questionnaire or interview (years 3, 5 and 10). We included low-trauma fractures before year 10, except those of the skull, face, hands, ankles and feet. We used a Cox proportional hazards model.
RESULTS: Among 4152 women, there were 583 fractures, with a mean follow-up time of 8.6 years. Among 1606 men, there were 116 fractures, with a mean follow-up time of 8.3 years. Increasing age, lower bone mineral density, prior fracture and prior falls were associated with increased risk of fracture. For low-trauma fractures, the concordance between predicted risk and fracture events (Harrell C) was 0.69 among women and 0.70 among men. For hip fractures, the concordance was 0.80 among women and 0.85 among men. The observed fracture risk was similar to the predicted risk in all quintiles of risk except the highest quintile of women, where it was lower. The net reclassification index (19.2%, 95% confidence interval [CI] 6.3% to 32.2%), favours the Dubbo nomogram over the current Canadian guidelines for men.
INTERPRETATION: The published nomograms provide good fracture-risk discrimination in a representative sample of the Canadian population.

Entities:  

Mesh:

Year:  2010        PMID: 21173069      PMCID: PMC3033952          DOI: 10.1503/cmaj.100458

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  29 in total

1.  Maximum likelihood estimation of agreement in the constant predictive probability model, and its relation to Cohen's kappa.

Authors:  M Aickin
Journal:  Biometrics       Date:  1990-06       Impact factor: 2.571

2.  Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results.

Authors:  H K Genant
Journal:  J Bone Miner Res       Date:  1995-06       Impact factor: 6.741

3.  Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  A Tenenhouse; L Joseph; N Kreiger; S Poliquin; T M Murray; L Blondeau; C Berger; D A Hanley; J C Prior
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

4.  Multiple imputation to account for missing data in a survey: estimating the prevalence of osteoporosis.

Authors:  Andrew Kmetic; Lawrence Joseph; Claudie Berger; Alan Tenenhouse
Journal:  Epidemiology       Date:  2002-07       Impact factor: 4.822

5.  Prediction of osteoporotic fractures by postural instability and bone density.

Authors:  T Nguyen; P Sambrook; P Kelly; G Jones; S Lord; J Freund; J Eisman
Journal:  BMJ       Date:  1993-10-30

6.  Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS).

Authors:  A A Ismail; S R Pye; W C Cockerill; M Lunt; A J Silman; J Reeve; D Banzer; L I Benevolenskaya; A Bhalla; J Bruges Armas; J B Cannata; C Cooper; P D Delmas; J Dequeker; G Dilsen; J A Falch; B Felsch; D Felsenberg; J D Finn; C Gennari; K Hoszowski; I Jajic; J Janott; O Johnell; J A Kanis; G Kragl; A Lopez Vaz; R Lorenc; G Lyritis; F Marchand; P Masaryk; C Matthis; T Miazgowski; M Naves-Diaz; H A P Pols; G Poor; A Rapado; H H Raspe; D M Reid; W Reisinger; C Scheidt-Nave; J Stepan; C Todd; K Weber; A D Woolf; T W O'Neill
Journal:  Osteoporos Int       Date:  2002-07       Impact factor: 4.507

7.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24

8.  Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents.

Authors:  Claudie Berger; Lisa Langsetmo; Lawrence Joseph; David A Hanley; K Shawn Davison; Robert Josse; Nancy Kreiger; Alan Tenenhouse; David Goltzman
Journal:  CMAJ       Date:  2008-06-17       Impact factor: 8.262

9.  Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials.

Authors:  Zhao Chen; Charles Kooperberg; Mary B Pettinger; Tamsen Bassford; Jane A Cauley; Andrea Z LaCroix; Cora E Lewis; Simon Kipersztok; Carolyn Borne; Rebecca D Jackson
Journal:  Menopause       Date:  2004 May-Jun       Impact factor: 2.953

10.  Prevalence of osteoporosis in Australian women: Geelong Osteoporosis Study.

Authors:  M J Henry; J A Pasco; G C Nicholson; E Seeman; M A Kotowicz
Journal:  J Clin Densitom       Date:  2000       Impact factor: 2.963

View more
  15 in total

1.  Fracture-risk calculators: Has their time come?

Authors:  Mark J Bolland
Journal:  CMAJ       Date:  2010-12-20       Impact factor: 8.262

2.  Predicting fractures in an international cohort using risk factor algorithms without BMD.

Authors:  Philip N Sambrook; Julie Flahive; Fred H Hooven; Steven Boonen; Roland Chapurlat; Robert Lindsay; Tuan V Nguyen; Adolfo Díez-Perez; Johannes Pfeilschifter; Susan L Greenspan; David Hosmer; J Coen Netelenbos; Jonathan D Adachi; Nelson B Watts; Cyrus Cooper; Christian Roux; Maurizio Rossini; Ethel S Siris; Stuart Silverman; Kenneth G Saag; Juliet E Compston; Andrea LaCroix; Stephen Gehlbach
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

Review 3.  Pitfalls in the external validation of FRAX.

Authors:  J A Kanis; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2011-11-26       Impact factor: 4.507

4.  Fracture risk assessment: state of the art, methodologically unsound, or poorly reported?

Authors:  Gary S Collins; Karl Michaëlsson
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

Review 5.  Comparison between various fracture risk assessment tools.

Authors:  W D Leslie; L M Lix
Journal:  Osteoporos Int       Date:  2014-01       Impact factor: 4.507

6.  Muscle Strength and Physical Performance Improve Fracture Risk Prediction Beyond Garvan and FRAX: The Osteoporotic Fractures in Men (MrOS) Study.

Authors:  Dima Alajlouni; Thach Tran; Dana Bliuc; Robert D Blank; Peggy M Cawthon; Eric S Orwoll; Jacqueline R Center
Journal:  J Bone Miner Res       Date:  2021-12-08       Impact factor: 6.741

7.  Fracture prediction from self-reported falls in routine clinical practice: a registry-based cohort study.

Authors:  W D Leslie; S N Morin; L M Lix; P Martineau; M Bryanton; E V McCloskey; H Johansson; N C Harvey; J A Kanis
Journal:  Osteoporos Int       Date:  2019-08-02       Impact factor: 4.507

Review 8.  Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review.

Authors:  S Nayak; D L Edwards; A A Saleh; S L Greenspan
Journal:  Osteoporos Int       Date:  2013-10-09       Impact factor: 4.507

Review 9.  Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review.

Authors:  Carolyn J Crandall
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

Review 10.  Overview of Fracture Prediction Tools.

Authors:  John A Kanis; Nicholas C Harvey; Helena Johansson; Anders Odén; Eugene V McCloskey; William D Leslie
Journal:  J Clin Densitom       Date:  2017-07-14       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.